Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

Tetrahydroxystilbene Glucoside may help prevent hair loss by blocking certain pathways that lead to cell death.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Prenatal diagnosis of trichothiodystrophy is possible in the second trimester using fetal eyebrow biopsy, with sulfur content analysis being more reliable.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Lithium can cause skin changes similar to mycosis fungoides.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

Promising cancer treatments were found, but the manufacturer closed.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

The early genes of a specific virus can cause abnormal skin cell growth and hair follicle changes.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.